A recent study showed that vaspin is a novel regulatory factor in hepatic steatosis that acts through the activation of AMPK via the GRP78 receptor, which effectively reduces hepatic fibrosis (Abdolahi et al., 2022). This evidence concerns the gene SERPINA12 and Hepatic fibrosis.